Enrolling by Invitation
⁶⁸Ga-DPA in the Lung Cancer Diagnosis
NCT07023068
- Conditions
- Lung Cancers, Lung Diseases, Lung Neoplasms, +5 more
- Locations
-
- 100730 Beijing, China
Clinical trial condition
Thoracic Neoplasms
Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.
8,031 public trials
1,839 recruiting studies
Thoracic Neoplasms trial results
Enrolling by Invitation
Liquid BiOpsy, Lung and Colon Cancer in AndaluciA
NCT06997458
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
- Locations
-
- Centre for Genomics and Oncological Research - Pfizer - University of Granada - Andalusian Regional Government (GENyO) Granada, Andalusia, Spain
Enrolling by Invitation
Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)
NCT06419179
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
- Locations
-
- University Hospital Cologne Cologne, North Rhine-Westphalia, Germany
Enrolling by Invitation
Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer
NCT06962449
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- Shanghai Chest Hospital Shanghai, Shanghai Municipality, China
Enrolling by Invitation
Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
NCT06690216
- Conditions
- Astrocytoma, Bronchial Neoplasms, Carcinoma, +30 more
- Locations
-
- Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan, Shandong, China
Enrolling by Invitation
Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients
NCT06883136
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Degan Lu Jinan, Shandong, China
- The First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China
Enrolling by Invitation
LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer
NCT06876675
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
- Locations
-
- Peking University Third Hospital Beijing, China
Enrolling by Invitation
Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic Ultrasound
NCT06848738
- Conditions
- Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +15 more
- Locations
-
- Department of Medicine, Zealand University Hospital, Næstved Næstved, Denmark
- Department of Respiratory Medicine, Odense University Hospital Odense, Denmark
- Department of Medicine, Zealand University Hospital, Roskilde Roskilde, Denmark
Enrolling by Invitation
Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC
NCT06816966
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Enrolling by Invitation
Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer
NCT06773156
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-stage Small Cell Lung Cancer (LS-SCLC), +8 more
- Locations
-
- The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China